Adjuvant treatment for ampullary cancer

Journal of the Pancreas

Volumn 12, Issue 4, 2011, Pages 362-363

  Kim, Richard ^a   Chabot, John ^b   Saif, Muhammad Wasif ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b New York Presbytarian Hospital ^*  (United States)

Author keywords

Ampulla of vater; Drug therapy; Gemcitabine; Pancreatic neoplasms

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C;

ADENOCARCINOMA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; HUMAN; OVERALL SURVIVAL; SURVIVAL RATE; VATER PAPILLA CARCINOMA;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; AMPULLA OF VATER; CHEMOTHERAPY, ADJUVANT; CHICAGO; COMBINED MODALITY THERAPY; COMMON BILE DUCT NEOPLASMS; CONGRESSES AS TOPIC; HUMANS; MEDICAL ONCOLOGY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 79960244409     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:721-31; discussion 31-3.
2. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006;244:10-5.
3. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: Analysis of 5-year survivors. Ann Surg 1998;227:821-31.
4. Lee JH, Whittington R, Williams NN, Berry MF, Vaughn DJ, Haller DG, et al. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys 2000;47:945-53.
5. Bhatia S, Miller RC, Haddock MG, Donohue JH, Krishnan S. Adjuvant therapy for ampullary carcinomas: The mayo clinic experience. Int J Radiat Oncol Biol Phys 2006;66:514-9.
6. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase iii trial of the eortc gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-82; discussion 82-4.
7. Sikora SS, Balachandran P, Dimri K, Rastogi N, Kumar A, Saxena R, et al. Adjuvant chemo-radiotherapy in ampullary cancers. Ejso 2005;31:158-63.
8. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer - a randomized controlled trial. JAMA 2007;297:267-77.
9. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase iii multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002;95:1685-95.
10. Neoptolemos JP MM, Cox TF, Valle JW, Palmer DH, Mcdonald A, et al. Ampullary cancer espac-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase iii trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of Vater. J Clin Oncol 2011;29:Abstr LBA4006